CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
暂无分享,去创建一个
David D. Smith | S. Forman | M. Jensen | S. Olivares | C. Kowolik | L. Cooper | M. Topp | N. Gonzalez | Timothy Pfeiffer | Sergio Gonzalez